Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone
3件: D02166 (Name: Mitoxantrone hydrochloride),
D03730 ,
D08224 (Name: Mitoxantrone)
2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13
2Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer,
Mitoxantrone
3件: D02166 (Name: Mitoxantrone hydrochloride),
D04318 ,
D08224 (Name: Mitoxantrone)
22件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
TOP2A,
TOP2B 💬
33件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13
3Mitoxantrone1件: Mitoxantrone2件: D02166 (Name: Mitoxantrone hydrochloride),
D08224 (Name: Mitoxantrone)
2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13
4Other: mitoxantrone - immunomodulator1件: Mitoxantrone2件: D02166 (Name: Mitoxantrone hydrochloride),
D08224 (Name: Mitoxantrone)
2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬1件: 13